These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 4609343)

  • 1. Bioavailability and efficacy of a sustained-release theophylline tablet.
    Mitenko PA; Ogilvie RI
    Clin Pharmacol Ther; 1974 Oct; 16(4):720-6. PubMed ID: 4609343
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
    Leeds NH; Gal P; Purohit AA; Walter JB
    J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from intravenous to sustained-release oral theophylline in pediatric patients with asthma.
    Clarke DF; Werbowsky OL; Grodin MA; Shargel L
    Drug Intell Clin Pharm; 1986 Sep; 20(9):700-3. PubMed ID: 3757784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new sustained-release theophylline tablet for children.
    Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
    Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of two sustained-release theophylline formulations versus an immediate-release preparation.
    Williams RL; Upton RA; Bostrom A
    J Asthma; 1983; 20(1):27-30. PubMed ID: 6343339
    [No Abstract]   [Full Text] [Related]  

  • 6. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational intravenous doses of theophylline.
    Mitenko PA; Ogilvie RI
    N Engl J Med; 1973 Sep; 289(12):600-3. PubMed ID: 4723589
    [No Abstract]   [Full Text] [Related]  

  • 9. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels.
    Rachelefsky GS; Katz RM; Siegel SC
    Ann Allergy; 1978 Apr; 40(4):252-7. PubMed ID: 345889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between theophylline pharmacokinetics and clinical relevance.
    Tinkelman DG; Edelman LJ; DeCouto J; Marquis NR
    J Asthma; 1984; 21(5):311-9. PubMed ID: 6389485
    [No Abstract]   [Full Text] [Related]  

  • 12. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.
    Lagas M; Jonkman JH
    Eur J Clin Pharmacol; 1983; 24(6):761-7. PubMed ID: 6884413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y
    Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the absorption kinetics of theophylline in the steady state, following multiple oral dosing of a sustained-release theophylline tablet formation to asthmatic patients.
    Takagi K; Hasegawa T; Ogura Y; Satake T; Mizukami Y
    Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3894-9. PubMed ID: 3815610
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release salbutamol tablets versus sustained release theophylline tablets in the control of reversible obstructive airways disease.
    Vyse T; Cochrane GM
    J Int Med Res; 1989; 17(1):93-8. PubMed ID: 2651178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets.
    Simons KJ; Frith EM; Simons FE
    J Pharm Sci; 1982 May; 71(5):505-11. PubMed ID: 7097493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenous theophylline.
    Mitenko PA; Ogilvie RI
    Clin Pharmacol Ther; 1973; 14(4):509-13. PubMed ID: 4723258
    [No Abstract]   [Full Text] [Related]  

  • 20. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.